View Older Stories View More Recent Stories

Feb 16, 2021 04:52PM Form SC 13G/A scPharmaceuticals Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:52PM Form SC 13G Kinnate Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:52PM Form SC 13G Lyra Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:52PM Form SC 13G CONCERT PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:52PM Form SC 13G/A Verastem, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:52PM Form SC 13G/A RELMADA THERAPEUTICS, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:52PM Form SC 13G/A Travere Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:52PM Form SC 13G Pandion Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:52PM Form SC 13G/A ChemoCentryx, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:51PM Form SC 13G Silverback Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:49PM Form SC 13G/A Orchard Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:48PM Form SC 13G/A ARDELYX, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:48PM Form SC 13G/A Phathom Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:48PM Form SC 13G GERON CORP Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:48PM Form SC 13G Dyne Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:48PM Form SC 13G Adverum Biotechnologies, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:48PM Form SC 13G Inhibrx, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:48PM Form SC 13G Helix Acquisition Corp Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:48PM Form SC 13G/A X4 Pharmaceuticals, Inc Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:48PM Form SC 13G Larimar Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:48PM Form SC 13G ARYA Sciences Acquisitio Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:48PM Form SC 13G NOVAVAX INC Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:48PM Form SC 13G/A RHYTHM PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:47PM Form SC 13G BCTG Acquisition Corp. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:47PM Form SC 13G/A Crinetics Pharmaceutical Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:47PM Form SC 13G Milestone Pharmaceutical Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:47PM Form SC 13G/A ZOGENIX, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:47PM Form SC 13G FIVE PRIME THERAPEUTICS, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:46PM Form SC 13G Verona Pharma plc Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:43PM Form SC 13G/A Prevail Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:40PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Dec 31
Feb 11, 2021 04:47PM Form SC 13G/A Iterum Therapeutics plc Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 11, 2021 08:15AM Cyteir Therapeutics Secures $80 Million in Series C Financing to Advance Clinical Trials of Lead RAD51 Program
Feb 10, 2021 04:50PM Form SC 13G/A TG THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 10, 2021 04:49PM Form SC 13G/A Keros Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 10, 2021 04:48PM Form SC 13G/A ARVINAS, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 10, 2021 04:47PM Form SC 13G/A Cardiff Oncology, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 10, 2021 04:35PM Form SC 13G/A TG THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 10, 2021 04:32PM Form SC 13G Keros Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 10, 2021 06:30AM Day One Announces $130 Million Series B Financing to Accelerate New Targeted Cancer Treatments for Children
Feb 8, 2021 05:17PM Form SC 13G/A Iterum Therapeutics plc Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 8, 2021 07:00AM Next-Gen Proteomics Company Nautilus Biotechnology to List on Nasdaq Through Merger with Arya Sciences Acquisition Corp III
Feb 5, 2021 07:05AM Orchard Therapeutics Plc (ORTX) Reports $150M Strategic PIPE Financing from 24.12M Share Sale at $6.22/Sh
Feb 5, 2021 07:00AM Orchard Therapeutics Announces $150 Million Strategic Financing
Feb 5, 2021 07:00AM Orchard Therapeutics Announces $150 Million Strategic Financing
Feb 4, 2021 09:47PM Form 3 Vor Biopharma Inc. For: Feb 04 Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 4, 2021 08:00AM PepGen Announces Appointment of James McArthur, Ph.D., as President and Chief Executive Officer
Jan 29, 2021 04:31PM Form SC 13G CytomX Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Jan 29, 2021 08:00AM Catabasis Pharmaceuticals Announces Acquisition of Quellis Biosciences Inc.
Jan 27, 2021 08:30AM Design Therapeutics Secures $125 Million in Series B Financing to Advance Pipeline of Genomic Medicines for Nucleotide Repeat Expansion Disorders
View More Recent Stories View Older Stories